Human Reproduction, Development, and Reproductive Technologies

Anatomy and Physiology of the Male Reproductive System

• Primary Physiological Functions:

  • Production of viable male gametes (spermatozoa) via spermatogenesis.

  • Synthesis and secretion of male sex steroid hormones, predominantly testosterone.

  • Production and composition of seminal fluid to nourish, protect, and transport sperm.

  • Deposition and discharge of spermatozoa into the female reproductive tract during copulation.

• Structural Classification of Male Reproductive Organs:

  • External Genitalia:

  • Scrotum: A fibromuscular cutaneous pouch suspended outside the abdominopelvic cavity. It houses and protects the testes while maintaining testicular temperature approximately $2^\circ\text{C} - 3^\circ\text{C}$ lower than core body temperature, an absolute physiological prerequisite for viable spermatogenesis.

  • Penis: The male organ of copulation and common conduit for urine excretion and semen ejaculation.

  • Internal Genitalia: Testes (male gonads).

  • Genital Duct System: Epididymides, vasa deferentia (ductus deferentia), ejaculatory ducts, and urethra.

  • Accessory Glands: Seminal vesicles, prostate gland, and Cowper's glands (bulbourethral glands).

• Testes (Testicles):

  • Paired, oval-shaped endocrine and exocrine glands located within the scrotal sac.

  • Encapsulated by a dense, fibrous collagenous connective tissue capsule termed the tunica albuginea.

  • Fibrous septa extend inward from the tunica albuginea, partitioning each testis into approximately $200 - 300$ wedge-shaped compartments termed lobules.

  • Each lobule contains $2 - 3$ tightly coiled, convoluted seminiferous tubules, representing the precise structural site of sperm formation.

  • Cellular Organization within Seminiferous Tubules:

  • Germinal Epithelium: Stratified specialized epithelium lining the tubules containing spermatogenic cells that divide and differentiate via meiosis into mature spermatozoa.

  • Sertoli Cells: Somatic support cells spanning the tubule basement membrane to the lumen, providing mechanical support, nutrients, and protection to developing germ cells.

  • Interstitial Cells of Leydig (Leydig Cells): Endocrine cells situated in the loose connective tissue stroma between seminiferous tubules that synthesize and secrete testosterone.

• Epididymis:

  • A crescent-shaped, tightly convoluted tubule measuring approximately $5\,\text{cm}$ in length (reaching up to $6\,\text{m}$ when uncoiled), applied to the posterior aspect of each testis.

  • Anatomically divided into three distinct segments: the head (caput), body (corpus), and tail (cauda).

  • Physiological Roles:

  • Serves as an anatomical reservoir to store spermatozoa for several months.

  • Facilitates functional sperm maturation, conferring forward motility and biochemical competence for fertilization.

• Vas Deferens (Ductus Deferens):

  • A thick-walled, muscular sperm duct that ascends out of the scrotum, traverses the inguinal canal into the pelvic cavity, and loops posterior to the urinary bladder.

  • The terminal portion dilates into an expanded reservoir termed the ampulla.

  • The ampulla converges with the excretory duct of the seminal vesicle to form the short, narrow ejaculatory duct.

  • The ejaculatory duct penetrates the substance of the prostate gland to empty into the prostatic portion of the urethra.

• Accessory Sex Glands:

  • Seminal Vesicles:

  • Paired, saccular glands situated posterior to the base of the bladder.

  • Secrete a viscous, alkaline seminal fluid rich in fructose, prostaglandins, and clotting proteins.

  • Fructose serves as the direct carbohydrate energy substrate utilized by sperm mitochondria for ATP synthesis; alkalinity counteracts acidic conditions and enhances sperm motility.

  • Prostate Gland:

  • A firm, walnut-sized gland encircling the base of the bladder and proximal urethra.

  • Contributes an alkaline, milky fluid containing enzymes that activate sperm motility and neutralize vaginal acidity, protecting sperm against low vaginal pH.

  • Cowper's Glands (Bulbourethral Glands):

  • Paired, pea-sized glands located inferior to the prostate adjacent to the membranous urethra.

  • Secrete an alkaline, clear mucus prior to ejaculation that lubricates the glans penis and neutralizes residual acidic urine within the urethra.

• The Penis and Mechanism of Erection:

  • Composed of three longitudinal columns of erectile tissue bound by dense fibrous tissue: paired dorsal corpora cavernosa and a single ventral corpus spongiosum surrounding the spongy urethra.

  • Glans Penis: The expanded, highly sensitive terminal end containing dense sensory nerve endings.

  • Prepuce (Foreskin): A circular fold of retractile skin covering the glans penis in uncircumcised males; surgical excision of this prepuce is known as circumcision.

  • Erection Physiology: Sexual stimulation prompts arterial dilation of dorsal and central cavernous arteries, engorging venous spaces of the spongy erectile tissue with blood. The resulting swelling compresses surrounding venous drainage, sustaining penile tumescence and rigidity.

  • An erect penis physically occludes the internal urethral sphincter, blocking urine flow and ensuring exclusive passage of semen during ejaculation.

• Semen Characteristics:

  • A greyish-white, opalescent bodily fluid expelled from the urethra during ejaculation under control of the sympathetic nervous system.

  • Typical ejaculate volume: $2.5\,\text{ml} - 5\,\text{ml}$.

  • Normal sperm density: $50\,\text{million} - 150\,\text{million}\,\text{sperm/ml}$.

  • Total sperm output per single ejaculation: approximately $700\,\text{million}\,\text{sperm}$.

Male Endocrinology and Spermatogenesis

• Hormonal Regulation of the Male System:

  • Hypothalamic-Pituitary-Gonadal Axis: The hypothalamus secretes Gonadotropin-Releasing Hormone (GnRH), prompting the anterior pituitary (hypophysis) to synthesize and secrete two gonadotrophic hormones: Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).

  • Luteinizing Hormone (LH): Binds to receptors on interstitial Leydig cells, directly stimulating the synthesis and secretion of testosterone.

  • Follicle-Stimulating Hormone (FSH): Acts synergistically with testosterone on the germinal epithelium and Sertoli cells to initiate and maintain spermatogenesis.

  • Testosterone:

  • Synthesized by interstitial cells of Leydig.

  • Drives development and maintenance of secondary sexual characteristics at puberty.

  • Preserves operational competence of internal ducts and accessory reproductive organs.

  • Governs male libido (sex drive).

  • Directly supports spermatogenesis.

  • Exerts negative feedback on the hypothalamus and anterior pituitary to regulate gonadotrophin secretion.

• Spermatogenesis Process:

  • The sequence of events by which diploid ($2n$) germ cells within the germinal epithelium of the seminiferous tubules undergo meiotic division and structural cytodifferentiation to produce mature haploid ($n$) spermatozoa.

  • Spermatogonia ($2n$) divide mitotically to produce primary spermatocytes ($2n$); each primary spermatocyte undergoes Meiosis I to form two secondary spermatocytes ($n$), which complete Meiosis II to yield four haploid spermatids ($n$).

  • Spermiogenesis transforms non-motile spherical spermatids into motile spermatozoa.

• Morphology and Ultrastructure of a Spermatozoon:

  • Head:

  • Approximates $5\,\mu\text{m}$ in length.

  • Houses a dense nucleus containing the haploid paternal chromosome set ($n = 23$).

  • Capped anteriorly by the acrosome, a modified lysosomal vesicle containing proteolytic enzymes (hyaluronidase and acrosin) essential for penetrating the corona radiata and zona pellucida of the ovum.

  • Neck: A constricted junctional segment containing centrioles that anchor the flagellar apparatus.

  • Middle Piece (Midpiece):

  • Contains an axoneme surrounded by a sheath of spiraled, densely packed mitochondria.

  • Generates adenosine triphosphate (ATP) via aerobic cellular respiration to fuel flagellar movement.

  • Tail (Principal and End Piece):

  • A specialized flagellum that beats in a wave-like sinusoidal pattern, rendering the spermatozoon motile.

  • Lifespan: Fully mature spermatozoa can survive and maintain fertilizing capacity for up to $48\,\text{hours}$ within the female reproductive tract post-ejaculation.

• Quantitative Comparison of Gametogenesis (Male vs. Female):

  • Meiotic Product Yield: Spermatogenesis produces $4$ viable spermatozoa per primary germ cell; oogenesis yields only $1$ functional mature ovum and degenerate polar bodies.

  • Production Rate: Males produce approximately $300\,000\,000\,\text{sperm/day}$; females release $1\,\text{ovum}$ every $28\,\text{days}$.

  • Lifetime Gamete Output: Males generate trillions ($10^{12}$) over a lifetime; females release between $100 - 500\,\text{mature ova}$ across their reproductive lifespan.

Anatomy and Physiology of the Female Reproductive System

• Structural Components of the Female Reproductive Tract:

  • Ovaries: Paired primary female gonads.

  • Fallopian Tubes (Oviducts/Uterine Tubes): Bilateral muscular conduits connecting ovaries to the uterus.

  • Uterus: Central muscular organ of gestation.

  • Cervix: Lower fibrous and muscular neck of the uterus.

  • Vagina: Copulatory canal and birth canal.

  • Vulva (External Genitalia): Mons pubis, labia majora, labia minora, clitoris, prepuce, urethral orifice, vaginal orifice, fourchette, and perineum.

• The Ovaries:

  • Almond-shaped organs positioned within the pelvic cavity on either side of the uterus, anchored by the ovarian ligament, broad ligament, and suspensory ligament.

  • Dual Functions:

  • Gametogenic: Production, maturation, and release of female ova (oogenesis and ovulation).

  • Endocrine: Synthesis and secretion of steroid hormones, primarily estrogens and progesterone.

  • Oocyte Reserve Lifespan Dynamics:

  • At birth, female ovaries contain approximately $1\,000\,000\,\text{primary oocytes}$ arrested in prophase I.

  • Due to continuous follicular atresia, approximately $300\,000\,\text{oocytes}$ remain at menarche (puberty).

  • Across the reproductive lifetime, only $300 - 400\,\text{oocytes}$ are ovulated.

  • Ovaries typically alternate release of a single mature ovum each successive cycle.

• Fallopian Tubes (Oviducts):

  • Muscular tubes extending laterally from the uterine horns toward each ovary.

  • Anatomical Segments: The expanded trumpet-shaped distal infundibulum terminates in mobile, finger-like projections called fimbriae that drape over the ovary; this leads to the wider ampulla and the narrow medial isthmus.

  • Microscopic Structure and Function:

  • Lined with ciliated columnar epithelium and non-ciliated secretory cells.

  • During ovulation, fringed fimbriae sweep across the ovarian surface to capture the ovulated oocyte into the lumen.

  • Ciliary beating coupled with rhythmic myosalpingeal peristaltic muscular contractions propel the ovum or developing embryo toward the uterus.

  • Serves as the precise physiological site of fertilization (specifically within the ampulla) and initial cleavage divisions of the zygote.

• The Uterus:

  • A hollow, thick-walled, inverted pear-shaped muscular organ situated in the pelvic cavity between the urinary bladder anteriorly and the rectum posteriorly.

  • Anatomical Regions: Superior dome-shaped fundus, central expanded body (corpus), and narrow inferior neck termed the cervix.

  • Histological Organization of the Uterine Wall:

  • Myometrium: A thick intermediate tunic composed of interlacing bundles of smooth involuntary muscle; undergoes substantial hypertrophy during pregnancy and contracts under oxytocin stimulation during labor.

  • Endometrium: The inner, highly vascularized mucosal lining containing uterine glands and spiral arteries. Subdivided into the superficial stratum functionalis (which thickens cyclically and sheds during menses) and the deep stratum basalis (which persists and regenerates the functional layer post-menstruation).

  • Uterine Functions:

  • Provides the anatomical site for blastocyst implantation, nourishment, and growth.

  • Expands massively across a standard gestation period of $40\,\text{weeks}$.

  • Contracts myometrial fibers to achieve fetal expulsion during birth.

  • Undergoes cyclic desquamation and bleeding (menstruation) in the absence of fertilization.

• The Cervix and Vagina:

  • Cervix: The lower, narrow segment that projects into the vaginal vault. Contains a central endocervical canal lined with mucus-secreting glands that alter mucus viscosity according to hormonal shifts.

  • Vagina: A distensible fibromuscular sheath extending from the cervix to the exterior vestibule.

  • Receives the erect penis and ejaculate during sexual intercourse.

  • Forms the lower portion of the birth canal during parturition.

  • Serves as the excretory passage for menstrual flow.

• Female External Genitalia (Vulva):

  • Mons Pubis: Subcutaneous adipose tissue cushion covering the pubic symphysis, covered with hair after puberty.

  • Labia Majora: Paired, prominent longitudinal cutaneous folds homologous to the male scrotum.

  • Labia Minora: Paired, delicate inner mucosal folds enclosing the vestibule.

  • Clitoris: An erectile structure situated at the anterior junction of the labia minora, capped by a prepuce; richly supplied with sensory nerves and erectile tissue homologous to the glans penis.

  • Note: The urinary bladder, urethra, and rectum are anatomically close to the genital tract, but belong strictly to the urinary and digestive systems.

Puberty and Gametogenesis Overview

• Biological Definition and Timeline:

  • Puberty: The transitional phase of adolescence marked by neuroendocrine maturation, rapid skeletal growth, development of secondary sexual characteristics, and attainment of fertility.

  • Onset: Typically between ages $9 - 13$ in females and $10 - 15$ in males.

  • Duration: Typically persists over $3 - 7\,\text{years}$ in both sexes.

• Endocrine Initiation of Puberty:

  • Triggered centrally within the brain by pulsed hypothalamic secretion of GnRH.

  • Stimulates the anterior pituitary gland (hypophysis) to release gonadotrophins: Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH).

  • Gonadotrophins enter the systemic circulation and act upon the gonads (testes or ovaries), inducing gametogenesis and secretion of gonadal sex steroid hormones (testosterone or estrogens/progesterone).

• Secondary Sexual Characteristics:

  • Males:

  • Broadening of the shoulders and thoracic cage.

  • Laryngeal enlargement and vocal fold thickening causing vocal deepening.

  • Maturation of testes, scrotal enlargement, and initiation of spermatogenesis.

  • Development of facial, axillary, chest, and leg hair.

  • Growth of skeletal muscle mass and bone density.

  • Growth of the penis and scrotum.

  • Appearance of pubic hair around the external genitalia.

  • Females:

  • Breast tissue budding and ductal/alveolar growth (thelarche).

  • Pelvic girdle widening and narrowing of the waist with characteristic gluteofemoral fat deposition.

  • Maturation of ovaries and initiation of cyclical ovulation.

  • Enlargement of the uterus and maturation of the vaginal canal.

  • Commencement of the menstrual cycle (menarche).

  • Growth of axillary hair, leg hair, and pubic hair around the external genitalia.

  • Shared Changes (Both Sexes):

  • Adolescent growth spurt in height and weight.

  • Hypertrophy and elevated secretion of sweat (eccrine and apocrine) glands, increasing perspiration.

  • Sebaceous glands secrete sebum, predisposing skin to acne.

  • Emergence of adult body odor.

  • Awakening of sexual thoughts, emotional drives, and libido.

  • Reorientation of psychosocial behaviors and social relationship dynamics.

• The Human Life Cycle:

  • Adults are diploid ($2n = 46\,\text{chromosomes}$).

  • Meiosis inside gonadal tissue (testes and ovaries) reduces the chromosome complement by half to produce haploid gametes ($n = 23\,\text{chromosomes}$: spermatozoa and ova).

  • Fertilization restores the diploid state, producing a single-celled diploid zygote ($2n = 46$).

  • Repeated mitotic divisions drive cleavage, blastogenesis, embryogenesis, and fetal development, culminating in the birth of a baby who grows into a diploid adult.

The Menstrual Cycle: Ovarian, Hormonal, and Uterine Cycles

• Overview of the Menstrual Cycle:

  • A rhythmic series of coordinated hormonal, structural, and physiological events designed to prepare the female reproductive system for potential pregnancy.

  • Duration varies naturally between $21 - 35\,\text{days}$, with an accepted physiological average of $28\,\text{days}$.

  • Comprises two synchronized, interconnected cycles:

  • Ovarian Cycle: Folliculogenesis, ovulation, and luteal formation within the ovary.

  • Uterine (Menstrual) Cycle: Sequential degeneration, proliferation, and secretory remodeling of the endometrial lining.

• Phases of the Ovarian Cycle:

  • Follicular Phase (Days 1–13):

  • GnRH stimulates anterior pituitary secretion of FSH.

  • FSH recruits a cohort of primordial follicles, stimulating their growth through primary and secondary follicular stages into a single dominant Graafian follicle (mature ovarian follicle).

  • As the follicle expands, its granulosa and theca interna cells secrete increasing quantities of estrogen (estradiol).

  • Ovulation (Day 14):

  • Peak threshold concentrations of estrogen trigger a sharp, transient neuroendocrine positive-feedback release of LH (the "LH surge") alongside a smaller FSH peak.

  • Within $24 - 36\,\text{hours}$ of the LH surge, the Graafian follicle ruptures through the ovarian tunica albuginea, expelling the secondary oocyte into the pelvic cavity to be captured by the Fallopian fimbriae.

  • Luteal Phase (Days 15–28):

  • The collapsed follicular remnants develop an internal blood clot (corpus hemorrhagicum) and, driven by LH, transform into the glandular corpus luteum.

  • The corpus luteum secretes high amounts of progesterone and moderate levels of estrogen.

  • In the absence of fertilization and pregnancy, the corpus luteum degenerates around Day 26–28 into a white fibrous scar called the corpus albicans.

• Phases of the Uterine (Endometrial) Cycle:

  • Menstrual Phase (Days 1–5):

  • Triggered by the abrupt regression of the corpus luteum and sudden withdrawal of progesterone and estrogen.

  • Endometrial spiral arterioles undergo spasmodic constriction, starving the stratum functionalis of oxygenated blood.

  • Ischemia leads to tissue necrosis, detachment of the stratum functionalis, and rupture of blood vessels.

  • Menstrual fluid (blood, serous fluid, and endometrial debris) is discharged through the vagina (menses).

  • Proliferative Phase (Days 6–14):

  • Parallels the ovarian follicular phase.

  • Rising estrogen levels stimulate mitoses within the persistent stratum basalis.

  • Endometrium rebuilds, doubling in thickness; straight tubular glands and spiral arteries proliferate.

  • Secretory Phase (Days 15–28):

  • Parallels the ovarian luteal phase.

  • Progesterone from the corpus luteum stimulates the rebuilt endometrium to become highly vascularized and edematous.

  • Uterine glands become tortuous, coiled, and actively secrete nutrient glycogen-rich fluid to nourish an implanting blastocyst.

• Basal Body Temperature Shifts:

  • During the pre-ovulatory follicular phase, basal body temperature remains at baseline (roughly $36.4^\circ\text{C} - 36.5^\circ\text{C}$).

  • Immediately prior to ovulation, a slight dip may occur, followed by a sustained thermal elevation of approximately $0.3^\circ\text{C} - 0.5^\circ\text{C}$ ($\ge 37.0^\circ\text{C}$) throughout the luteal phase, driven by the thermogenic action of progesterone.

• Hormone Actions and Negative/Positive Feedback Controls:

  • Follicle-Stimulating Hormone (FSH): Produced by the anterior pituitary; initiates follicular growth and stimulates granulosa cells to produce estrogen.

  • Estrogen (Estradiol): Secreted by developing ovarian follicles. Thickens the endometrium; low/moderate levels exert negative feedback on FSH; high, sustained pre-ovulatory levels switch to positive feedback, triggering the LH surge.

  • Luteinizing Hormone (LH): Produced by the anterior pituitary; drives final follicular maturation, induces ovulation, and transforms ruptured follicles into the corpus luteum.

  • Progesterone: Produced by the corpus luteum (and later the placenta). Stabilizes and maintains the secretory endometrium, inhibits myometrial contractility, and exerts strong negative feedback on the hypothalamus and anterior pituitary to suppress further FSH and LH secretion, preventing new follicular recruitment.

  • End-of-Cycle Resolution: If fertilization fails, corpus luteum involution causes a steep drop in progesterone and estrogen. This removes the negative feedback suppression of the pituitary gland, allowing FSH secretion to rise again and initiate the subsequent cycle.

Fertilization, Cleavage, and Implantation

• Fertilization:

  • The union and fusion of the haploid nucleus of a spermatozoon ($n = 23$) with the haploid nucleus of an ovum ($n = 23$), producing a single-celled diploid zygote ($2n = 46$).

  • Occurs in the ampulla of the Fallopian tube within $12 - 24\,\text{hours}$ following ovulation.

  • Capacitated sperm penetrate the outer cellular corona radiata and release acrosomal enzymes to digest through the acellular zona pellucida.

  • Fusion of the first sperm membrane with the oocyte oolemma triggers cortical granule exocytosis, hardening the zona pellucida (cortical reaction/slow block to polyspermy) to ensure mono-spermic fertilization.

• Pre-Implantation Cleavage and Embryonic Migration Timeline:

  • Day 0: Successful fertilization event in the ampulla forms the zygote.

  • Day 1: First mitotic cleavage division yields a $2\text{-cell}$ pre-embryo.

  • Day 2: Second cleavage division yields a $4\text{-cell}$ pre-embryo.

  • Day 3–4: Continued mitotic divisions generate an $8\text{-cell}$ uncompacted stage, followed by cell compaction to form a solid berry-like sphere of $16 - 32\,\text{cells}$ termed the morula.

  • Day 4–5: The morula reaches the uterine cavity. Fluid penetrates between cells, creating a fluid-filled cavity (blastocoel) and transforming the morula into a blastocyst.

  • Trophectoderm (Trophoblast): An outer monolayer of flattened epithelial cells dedicated to forming extraembryonic membranes and the fetal contribution to the placenta.

  • Inner Cell Mass (Embryoblast): An internal cluster of pluripotent cells destined to form the embryo proper.

  • Day 6–7: The blastocyst "hatches" by enzymatic degradation from the confining zona pellucida.

  • Day 8–9: Implantation: The trophoblast attaches to, erodes, and embeds into the receptive, secretory endometrial stroma on the posterior or anterior uterine wall.

  • The inner cell mass differentiates into a bilaminar embryonic disc composed of the epiblast and hypoblast.

• Human Chorionic Gonadotropin (hCG):

  • Secreted by the syncytiotrophoblast of the implanting blastocyst.

  • Prevents the natural degeneration of the ovarian corpus luteum, preserving its structural integrity and sustaining high progesterone output.

  • Maintains the thick endometrium and prevents menstrual shedding.

  • Serves as the biomarker detected in biological pregnancy assays; detectable in maternal serum within $1 - 2\,\text{weeks}$ of conception, and in maternal urine within $4 - 6\,\text{weeks}$.

Gestation: Extraembryonic Membranes, Placenta, and Umbilical Cord

• Embryo vs. Fetus Definition and Gestation Timeline:

  • Embryo: Conceptus from the time of fertilization through the end of the eighth week ($8\,\text{weeks}$), a phase marked by organogenesis.

  • Fetus: From the ninth week ($9\,\text{weeks}$ / $2\,\text{months}$) until delivery at full term, characterized by tissue maturation and somatic growth.

  • Gestation Duration: Lasts $40\,\text{weeks}$ ($280\,\text{days}$ or approximately $9\,\text{calendar months}$), calculated from the first day of the last menstrual period (LMP).

  • Divided into three clinical trimesters:

  • First Trimester: Weeks $0 - 12$.

  • Second Trimester: Weeks $13 - 28$.

  • Third Trimester: Weeks $29 - 40$.

• The Amnion and Amniotic Fluid:

  • Amnion: A thin, tough, transparent inner extraembryonic membrane that forms around the embryo during weeks $3 - 4$, creating the fluid-filled amniotic cavity.

  • Functions of Amniotic Fluid:

  • Acts as a physical shock absorber, shielding the fragile fetus from external mechanical trauma.

  • Permits symmetrical external growth and uninhibited fetal movement, preventing structural distortions and aiding musculoskeletal development.

  • Maintains thermal homeostasis, insulating the fetus at a stable internal temperature.

  • Serves as a medium in which the fetus swallows fluid and "practices" breathing motions, conditioning pulmonary and gastrointestinal tissues.

  • Accommodates fetal urine output.

  • Prevents adhesion of the amnion to developing fetal cutaneous surfaces, preventing desiccation.

• The Chorion:

  • The outermost extraembryonic membrane surrounding the amnion, embryo, and yolk sac.

  • Extends branching, vascularized projections termed chorionic villi deeply into the maternal endometrial functionalis (decidua basalis).

  • The chorionic villi arborize extensively, creating a large surface area for physiological exchange between maternal and fetal systems, ultimately forming the fetal component of the mature placenta.

• Structure and Hemodynamics of the Placenta:

  • A temporary, discoid fetomaternal organ connecting the developing fetus directly to the maternal uterine circulation.

  • Maternal arterial blood is pumped from spiral endometrial arteries into the intervillous spaces.

  • These spaces bathe the outer syncytial surfaces of the fetal chorionic villi, which contain loops of fetal capillaries.

  • Separation of Circulations: Maternal and fetal blood never mix directly; they are separated by the placental barrier (fetal capillary endothelium, embryonic connective tissue, and trophoblast). All molecular exchange occurs across this barrier via passive diffusion, facilitated transport, and active transport.

• Comprehensive Functions of the Placenta:

  • Respiration: Oxygen ($O_2$) diffuses down its concentration gradient from maternal blood to fetal blood; carbon dioxide ($CO_2$) diffuses from fetal blood into maternal veins for maternal pulmonary clearance.

  • Nutrition: Delivers dissolved essential nutrients (glucose, amino acids, fatty acids, vitamins, minerals, water) from maternal circulation to the fetus.

  • Excretion: Transfers fetal metabolic byproducts (urea, uric acid, creatinine) into maternal blood for renal clearance.

  • Passive Immunity: Transports maternal Immunoglobulin G (IgG) antibodies across the placental membrane into fetal blood, providing passive immunity against infectious pathogens during gestation and early infancy.

  • Microfilter Barrier: Filters out certain maternal microorganisms, though various viruses, drugs, and toxins can traverse the membrane.

  • Endocrine Secretion: Produces hCG during early gestation; by week $12$, it takes over steroidogenesis from the regressing corpus luteum, secreting large quantities of progesterone to prevent uterine contractions and high levels of estrogens to promote myometrial, vascular, and mammary growth.

• The Umbilical Cord:

  • Develops during the fourth week ($4\,\text{weeks}$) of pregnancy, linking the fetal umbilicus to the chorionic plate of the placenta.

  • Elongates progressively with fetal growth, filled with a gelatinous connective tissue matrix termed Wharton's jelly.

  • Vascular Architecture:

  • Two Umbilical Arteries: Transport deoxygenated, nutrient-depleted fetal blood carrying metabolic waste products ($CO_2$, urea) from the internal iliac arteries of the fetus to the chorionic villi of the placenta.

  • One Umbilical Vein: Transports oxygenated, nutrient-rich blood from the placental villi back to the fetal heart and systemic circulation via the ductus venosus.

Parturition and Childbirth Physiology

• Parturition (Birth):

  • The physiological process by which the full-term fetus, its surrounding membranes, and the placenta are expelled from the uterus through the birth canal.

  • Occurs approximately $40\,\text{weeks}$ post-fertilization.

  • Approximately $2 - 3\,\text{weeks}$ before labor, the fetus undergoes lightening, engaging head-first (cephalic presentation) into the maternal pelvic inlet.

  • Elevated maternal estrogen levels increase myometrial sensitivity to oxytocin and upregulate gap junctions between uterine smooth muscle cells.

• Neuroendocrine Positive Feedback Control of Labor:

  • Early, spontaneous myometrial contractions push the rigid fetal head downward against the internal os of the cervix.

  • Mechanical stretch receptors in the cervix detect distension and transmit afferent neural signals up the spinal cord to the hypothalamus.

  • The hypothalamus prompts the posterior pituitary gland to release oxytocin into the bloodstream.

  • Oxytocin targets the myometrium, binding receptors to stimulate more frequent and powerful smooth muscle contractions.

  • Stronger contractions drive the fetal head harder against the cervix, generating greater cervical stretch.

  • This self-amplifying positive feedback cycle repeats with escalating intensity until the baby is expelled, which eliminates cervical stretch and breaks the loop.

• Clinical Stages of Childbirth (Natural Labor):

  • 1. Dilation Stage:

  • The initial and longest phase of labor.

  • Uterine contractions become coordinated and rhythmic, pulling the lower uterine segment upward and thinning (effacing) and dilating the cervix until it reaches full dilation ($10\,\text{cm}$).

  • The hydrostatic pressure of the amniotic sac ruptures the membranes ("water breaking"), releasing amniotic fluid through the vagina.

  • The fetal head descends into the pelvic cavity.

  • 2. Expulsion Stage:

  • Extends from full cervical dilation ($10\,\text{cm}$) to the complete delivery of the infant.

  • Powerful involuntary myometrial contractions, coupled with maternal abdominal bearing-down efforts, propel the neonate through the dilated cervix and vagina.

  • The baby crowns, emerges into the external environment, and takes its first breath of air.

  • The umbilical cord is clamped and severed; the remaining stump attached to the infant's abdomen undergoes necrosis and cicatrization over subsequent weeks, forming the navel (umbilicus).

  • 3. Placental Stage:

  • Occurs within $15 - 30\,\text{minutes}$ following delivery of the infant.

  • Continued rhythmic uterine contractions cause the uterine cavity to constrict, shearing the placenta away from the decidual wall.

  • The detached placenta, umbilical remnants, and associated extraembryonic membranes are expelled through the birth canal as the afterbirth.

• Caesarean Section (C-Section):

  • A major surgical procedure in which the infant is delivered through laparotomy and hysterotomy incisions in the maternal abdominal and uterine walls.

  • Surgical Incision Varieties: Can be performed using a traditional vertical incision (longitudinal through the midline) or a horizontal incision (low-transverse "bikini" cut through the lower uterine segment).

  • Procedural Sequence:

  • 1. Administration of regional anesthesia (epidural or spinal block).

  • 2. Sterile surgical preparation of the patient.

  • 3. Incision through abdominal skin, subcutaneous tissue, fascia, peritoneum, and myometrium.

  • 4. Manual extraction of the infant.

  • 5. Manual separation and delivery of the placenta.

  • 6. Systematic layered surgical suturing of the uterine incision and abdominal wall.

• Summary of Hormones in Pregnancy and Parturition:

  • Human Chorionic Gonadotropin (hCG): Secreted early by the syncytiotrophoblast; sustains the corpus luteum to maintain progesterone production during the first trimester.

  • Progesterone: Secreted initially by the corpus luteum and subsequently by the placenta; maintains the functional endometrium, suppresses myometrial excitability to prevent preterm contractions, and prepares mammary glands for lactation.

  • Estrogen: Secreted by the corpus luteum and placenta; drives uterine growth, stimulates maternal uterine blood flow, promotes development of fetal organs, and upregulates oxytocin receptors in the myometrium.

  • Relaxin: Secreted by the corpus luteum and placenta; increases flexibility of the pubic symphysis, softens pelvic ligaments, dilates the cervix, and inhibits myometrial contractions prior to term.

  • Oxytocin: Synthesized in the hypothalamus and stored in the posterior pituitary; stimulates powerful rhythmic uterine contractions during labor and triggers milk ejection ("let-down") during lactation.

  • Prolactin: Synthesized and secreted by the anterior pituitary; promotes glandular breast development during gestation and stimulates milk synthesis within mammary alveolar cells postpartum; regulated negatively by dopamine.

Lactation and Postnatal Nutrition

• Functional Anatomy of the Mammary Glands:

  • Modified apocrine sweat glands situated over the pectoralis major muscles of the anterior chest wall, anchored by fibrous Cooper's ligaments and supported by the ribs.

  • Composed of $15 - 20\,\text{glandular lobes}$ embedded within protective adipose and fibrous connective tissue.

  • Each lobe is organized into smaller lobules containing clusters of milk-secreting alveoli lined with cuboidal lactocytes and surrounded by contractile myoepithelial cells.

  • Alveoli drain into intralobular ducts that merge into larger lactiferous ducts, which dilate into ampullae before opening independently onto the surface of the nipple.

• Endocrine Control of Lactation:

  • Lactogenesis (Milk Production):

  • During gestation, elevated levels of estrogen and progesterone stimulate extensive proliferation of lactiferous ducts and alveoli, while competitively inhibiting the secretory action of prolactin.

  • The abrupt expulsion of the placenta removes this circulating steroid block.

  • In response, the anterior pituitary secretes high levels of prolactin, which stimulates the alveolar glandular cells to synthesize and secrete milk into the alveolar lumens.

  • The Milk Ejection ("Let-Down") Reflex:

  • When the neonate suckles at the breast, tactile mechanoreceptors within the nipple-areolar complex generate afferent nerve impulses via the spinal cord to the hypothalamus.

  • The hypothalamus prompts the posterior pituitary to secrete oxytocin into the bloodstream.

  • Oxytocin binds to receptors on the myoepithelial cells surrounding the alveoli, causing them to contract.

  • This contraction forces stored milk out of the alveoli, through the lactiferous ducts, and out through the nipple pores for the feeding infant.

• Comparative Evaluation: Human Breast Milk vs. Formula Milk:

  • Cost: Breast milk is naturally produced and free; manufactured formula milk is expensive.

  • Preparation and Availability: Breast milk is immediately available on demand without preparation; formula requires sterile water, measuring, bottle preparation, and warming.

  • Microbial Safety: Breast milk is clean and sterile directly from the breast; formula milk carries risk of microbiological contamination from unsterilized bottles or contaminated water.

  • Temperature Regulation: Breast milk is delivered at body temperature; formula requires artificial heating and temperature checks.

  • Immunological Protection: Breast milk contains maternal antibodies (notably secretory IgA), enzymes (lysozyme), and leukocytes that provide passive immunity against gastrointestinal and respiratory infections; formula provides zero antibodies.

  • Cognitive Development: Breast milk contains specialized long-chain polyunsaturated fatty acids (such as DHA and ARA) that support central nervous system and retinal development; formula does not replicate all biological brain-development factors.

  • Allergenic Potential: Breast milk is hypoallergenic and easily digested; bovine-milk-based formula carries risk of allergies to foreign dairy proteins.

  • Psychosocial Attachment: Direct breastfeeding promotes maternal-infant skin-to-skin contact, stimulating reciprocal oxytocin release and bonding; bottle feeding lacks this specific biological connection.

Methods of Contraception

• Classification of Contraceptive Modalities:

  • Natural Methods: Behavioral practices aimed at preventing fertilization without devices or exogenous chemicals.

  • Abstinence: Total refraining from sexual intercourse. The only $100\%$ effective method for preventing pregnancy and sexually transmitted infections.

  • Rhythm Method (Periodic Abstinence / Natural Family Planning): Couples abstain from sexual intercourse during the fertile window around ovulation (days preceding, during, and following ovulation). Unreliable for individuals with irregular cycles, as estimating exact ovulation timing is imprecise.

  • Withdrawal (Coitus Interruptus): The male withdraws the penis from the vagina prior to ejaculation. Has a high failure rate because pre-ejaculatory fluid often contains viable spermatozoa, and the method relies heavily on male self-control and timing.

  • Douching: Attempting to wash out semen from the vagina with water or chemical solutions immediately post-coitus. Ineffective; the physical fluid flush often propels remaining sperm up through the cervix into the uterine cavity, increasing pregnancy risk.

  • Mechanical and Barrier Methods: Physical devices designed to prevent sperm from entering the female genital tract.

  • Male Condom: A thin sheath of latex rubber unrolled over the erect penis before coitus. Collects ejaculate and prevents sperm from entering the vagina; single-use only. Highly effective at preventing pregnancy and provides strong protection against STIs/HIV.

  • Female Condom (Femidom): A pre-lubricated polyurethane sheath inserted into the vaginal vault with an internal retaining ring over the cervix and an external ring over the vulva. Receives the penis and prevents contact between seminal fluid and the vaginal mucosa.

  • Diaphragm: A dome-shaped silicone or soft rubber barrier inserted into the vagina to fit over the cervix, preventing sperm from entering the uterus. Must be fitted by a clinician and is reused alongside chemical spermicides.

  • Intrauterine Device (IUD): A small, T-shaped or coiled plastic device wrapped in metallic copper inserted into the uterine cavity by a trained medical professional. Induces a sterile inflammatory response in the endometrium that is toxic to sperm and prevents blastocyst implantation; functional lifespan ranges between $5 - 10\,\text{years}$.

  • Chemical Methods:

  • Spermicides: Chemical creams, gels, foams, or suppositories placed into the vagina around the cervix prior to coitus. Contain surfactants (such as nonoxynol-9) that immobilize and lyse sperm cell membranes; typically used in combination with barrier devices.

  • Hormonal Methods: Exogenous synthetic steroids that suppress endogenous gonadotrophins to prevent ovulation, alter cervical mucus consistency, or thin the endometrium.

  • Combined Oral Contraceptive Pill: Contains synthetic estrogen and progesterone. High circulating steroid levels exert continuous negative feedback on the anterior pituitary, suppressing FSH and LH secretion, which prevents follicular maturation and ovulation. Regimen involves taking $1\,\text{active pill}$ daily for $21\,\text{consecutive days}$, followed by $7\,\text{placebo pills}$ during which withdrawal bleeding occurs. Highly effective.

  • Contraceptive Injection: Intramuscular or subcutaneous depot injection of synthetic progesterone administered every $3\,\text{months}$. Suppresses the LH surge to prevent ovulation, thickens cervical mucus, and induces endometrial atrophy.

  • Contraceptive Patch: A transdermal adhesive patch releasing estrogen and progesterone across the skin into the bloodstream. Applied to the buttocks, lower abdomen, or upper arm; replaced weekly for $3\,\text{weeks}$, followed by a patch-free fourth week during which withdrawal menses occurs.

  • Subdermal Contraceptive Implant: A small, flexible silastic rod containing slow-release progesterone inserted under the skin of the upper arm by a clinician. Suppresses ovulation and thickens cervical mucus for up to $3\,\text{years}$; can cause irregular spotting or secondary amenorrhea.

  • Surgical Sterilization Methods: Permanent surgical interventions that interrupt gamete transport ducts.

  • Vasectomy (Male Sterilization): A minor surgical procedure performed under local anesthesia. The bilateral vasa deferentia are accessed via scrotal incisions, cut, and the ends ligated or cauterized. Ejaculation continues normally, but the fluid contains only accessory gland secretions devoid of spermatozoa.

  • Tubal Ligation (Female Sterilization): A laparoscopic or mini-laparotomy surgical procedure performed under anesthesia. The bilateral Fallopian tubes are cut, clipped, or cauterized, permanently barring sperm from ascending toward the ovum and preventing ovum transport to the uterus. More invasive with higher operative risks than vasectomy.

Sexually Transmitted Infections (STIs)

• Epidemiology and Transmission:

  • Sexually Transmitted Infections (STIs) are infectious diseases transmitted predominantly through unprotected sexual intercourse (vaginal, anal, or oral coitus), direct genital skin-to-skin contact, or sharing contaminated sex toys.

  • Vertical transmission can also occur from an infected mother to her child during pregnancy, labor, or lactation.

  • Causative agents span diverse pathogenic microorganisms: viruses, bacteria, and fungi.

  • Infection risk rises with the number of unprotected sexual encounters and sexual partners.

• Bacterial STIs:

  • Gonorrhoea:

  • Etiology: Caused by the Gram-negative diplococcus bacterium Neisseria gonorrhoeae.

  • Modes of Transmission: Penetrative vaginal or anal sex, oral sex (orogenital transmission), direct contact with contaminated genital secretions on fingers, or sharing unwashed sex toys.

  • Manifestations: Purulent urethral or vaginal discharge, dysuria (painful urination), pelvic inflammatory disease (PID), and secondary tubal scarring that can cause female sterility.

  • Medical Management: A targeted course of systemic antibiotic therapy administered orally or intramuscularly.

  • Syphilis:

  • Etiology: Caused by the spirochete bacterium Treponema pallidum.

  • Modes of Transmission: Direct skin-to-skin contact with active syphilitic lesions, vaginal, anal, or oral sexual contact, and transplacental transmission from mother to fetus.

  • Clinical Progression: Begins with a painless primary ulcer (chancre) at the inoculation site, progressing to a generalized secondary stage with diffuse maculopapular skin eruptions on the trunk, palms, and soles; this is followed by a prolonged, asymptomatic latent stage. Untreated tertiary syphilis causes destructive gummatous lesions, cardiovascular complications (aortitis), and irreversible neurosyphilis leading to motor paralysis and dementia.

  • Medical Management: Regimens of parenteral penicillin antibiotics. Patients must abstain from sexual contact until serological cure is confirmed.

• Viral and Fungal Pathogens:

  • Viral Infections: Human Immunodeficiency Virus (HIV/AIDS), Genital Herpes (Herpes Simplex Virus), and Genital Warts (Human Papillomavirus - HPV).

  • Fungal Infections: Thrush (Candidiasis, caused by Candida albicans).

• Prevention and Risk Mitigation of HIV/AIDS and STIs:

  • Practicing complete sexual abstinence.

  • Avoiding recreational drugs and alcohol to prevent impaired judgment and risky sexual behaviors.

  • Mutual fidelity within a monogamous relationship between two uninfected partners.

  • Consistent, correct use of latex barrier condoms during every sexual encounter to block transmission of infectious genital secretions.

Infertility and Assisted Reproductive Technologies

• Etiology of Infertility:

  • Infertility is defined clinically as the inability of a couple to achieve pregnancy following $12\,\text{months}$ of regular, unprotected sexual intercourse.

  • Male Infertility Factors:

  • Oligospermia (subnormal sperm count) or azoospermia (complete absence of sperm).

  • Asthenospermia (impaired sperm motility, such as axonemal or flagellar structural defects).

  • Teratospermia (high percentage of structurally abnormal sperm, such as defective acrosomes or multiple heads).

  • Female Infertility Factors:

  • Anovulation or oligo-ovulation secondary to endocrine imbalances (e.g., polycystic ovary syndrome, hypothalamic amenorrhea).

  • Mechanical occlusion or scarring of the Fallopian tubes (salpingitis, pelvic inflammatory disease).

  • Endometriosis (ectopic implantation and bleeding of endometrial tissue in the peritoneal cavity).

  • Anatomical uterine pathologies (leiomyomas/fibroids, intrauterine adhesions).

  • Advanced maternal age, chronic stress, or structural defects of the cervix.

• Clinical Management and Reproductive Interventions:

  • Fertility Drugs: Exogenous gonadotrophic preparations containing recombinant or purified FSH and LH injected into the female to stimulate multifollicular development and induce ovulation.

  • Artificial Insemination (AI):

  • The mechanical deposition of prepared, concentrated sperm directly into the female reproductive tract (intrauterine insemination).

  • Can use sperm collected from the partner or from a screened donor.

  • Gamete Intra-Fallopian Transfer (GIFT): Surgical harvesting of ova and sperm, which are mixed and immediately transferred via laparoscopy into the ampulla of the Fallopian tube for in vivo fertilization.

  • Corrective Reproductive Surgery: Laparoscopic excision of endometriosis, surgical unblocking of salpingeal adhesions, or myomectomy to resect obstructing fibroids.

• In Vitro Fertilization (IVF) Procedure:

  • Step 1: Ovarian Hyperstimulation: Exogenous FSH and LH are administered to induce the simultaneous maturation of multiple ovarian follicles.

  • Step 2: Oocyte Retrieval: Mature ova are harvested from ovarian follicles using a transvaginal ultrasound-guided aspiration needle.

  • Step 3: In Vitro Fertilization: Harvested ova are placed into a nutrient liquid culture medium in a Petri dish; washed, hyperactivated sperm are added to permit fertilization.

  • Step 4: Embryonic Incubation: Fertilized zygotes are cultured in vitro, allowing cleavage divisions to progress to the $4 - 8\,\text{cell}$ embryo stage or blastocyst stage.

  • Step 5: Embryo Transfer: Typically, $1 - 3\,\text{viable embryos}$ are loaded into a fine catheter and transferred through the cervix into the uterine cavity for implantation.

• Evaluation of Assisted Reproductive Technologies (ART):

  • Clinical Benefits: Provides a pathway to biological parenthood for individuals and couples facing structural, genetic, or unexplained infertility.

  • Associated Medical and Psychological Risks:

  • High physical and emotional stress over repetitive treatment cycles.

  • Relatively low live-birth success rates per individual treatment cycle.

  • Increased incidence of multiple gestations (twins, triplets) when transferring multiple embryos, carrying risks of premature labor, low birth weight, and neonatal morbidity.

  • Moral and Bioethical Dilemmas:

  • Disposition and legal status of surplus, cryopreserved human embryos.

  • Limitations on the maximum duration of embryonic cryostorage.

  • Posthumous reproduction (utilizing frozen gametes or embryos following the death of a contributing partner).

Surrogacy: Procedures, Ethics, and Legal Framework

• Definition and Indications:

  • Surrogacy: An arrangement in which a surrogate mother carries a pregnancy and undergoes childbirth on behalf of intended (commissioning) parents, relinquishing parental rights at birth.

  • Clinical and Social Indications:

  • Absolute uterine-factor infertility (congenital uterine agenesis/Mayer-Rokitansky-Küster-Hauser syndrome, prior hysterectomy).

  • Severe intrauterine adhesions or recurrent implantation failure.

  • Severe maternal medical conditions where pregnancy poses an immediate threat to life (e.g., severe pulmonary hypertension, severe heart disease).

  • Risk of passing on a lethal or debilitating hereditary maternal genetic mutation.

  • Same-sex male couples or single intended parents seeking biological children.

• Biological Classifications of Surrogacy:

  • Traditional (Partial) Surrogacy: The surrogate mother donates her own ovum, which is fertilized via artificial insemination using the commissioning father's or donor's sperm. The surrogate is genetically related to the resulting child.

  • Gestational (Full) Surrogacy: The commissioning mother's ovum (or a donor ovum) is fertilized in vitro with the commissioning father's (or donor's) sperm; the resulting blastocyst is transferred into the surrogate's prepared uterus. The surrogate has no genetic relationship to the child.

• Legal Regulations (South African Context):

  • Governed by Chapter 19 of the Children's Act (Act No. 38 of 2005).

  • High Court Confirmation: A surrogacy agreement must be reviewed and confirmed by the High Court prior to any assisted reproductive procedures or conception.

  • Prohibition of Commercial Surrogacy: Commercial surrogacy is illegal. Surrogacy must be altruistic; it is an offense to provide or receive payments, commercial compensation, or rewards for acting as a surrogate.

  • Permitted Reimbursements: Commissioning parents may only reimburse documented, reasonable pregnancy-related expenses: medical, diagnostic, and hospitalization costs, psychological and social work assessments, specialized legal counsel fees, and verified loss of employment earnings suffered by the surrogate as a direct consequence of the pregnancy.

Teratogenic Effects: Fetal Alcohol Syndrome

• Etiology and Pathophysiology:

  • Caused by maternal consumption of ethanol (alcohol) during pregnancy.

  • Ethanol is a teratogenic agent that crosses the placental barrier, entering the fetal circulation.

  • Because the immature fetal liver lacks functional alcohol dehydrogenase enzyme systems to metabolize alcohol, high concentrations of ethanol and acetaldehyde circulate within fetal tissues, disrupting cell migration, cellular division, protein synthesis, and neurogenesis.

• Characteristic Phenotypic Craniofacial Dysmorphology:

  • Microcephaly: Disproportionately small cranial circumference reflecting impaired brain development.

  • Low Nasal Bridge: Depressed nasal root.

  • Epicanthal Folds: Vertical skin folds covering the inner canthi of the eyes.

  • Short Palpebral Fissures: Abnormally small, narrowed horizontal eye openings.

  • Flat Midface: Hypoplasia of the maxilla with a short, upturned nose.

  • Smooth/Indistinct Philtrum: Flatted, shallow vertical groove between the base of the nose and the upper lip.

  • Thin Upper Lip: Markedly thinned vermilion border of the upper lip.

  • Micrognathia: Abnormally small, underdeveloped mandible (receding jaw).

  • Minor Ear Abnormalities: Low-set, posteriorly rotated, or poorly formed external auricles.

• Systemic and Neurodevelopmental Deficits:

  • Intrauterine growth restriction (IUGR) and permanent postnatal growth retardation.

  • Central nervous system damage causing intellectual disabilities, learning disorders, behavioral problems, poor impulse control, and memory deficits.

Multiple Gestation: Biology of Twinning

• Monozygotic (Identical) Twins:

  • Originate from a single fertilization event involving one ovum and one sperm.

  • The resulting single diploid zygote splits into two independent cell masses during early cleavage divisions or blastocyst development.

  • Because they share identical genomes, monozygotic twins are always the same chromosomal sex and possess near-identical physical characteristics.

  • Placental and Amniotic Configurations (Timing of Splitting):

  • Cleavage during days $1 - 3$ (morula stage) yields dichorionic, diamniotic twins (separate placentas, separate amniotic sacs).

  • Cleavage during days $4 - 8$ (blastocyst stage) yields monochorionic, diamniotic twins (shared placenta, separate amniotic sacs; the most common configuration).

  • Cleavage during days $8 - 12$ yields monochorionic, monoamniotic twins (shared placenta, shared single amniotic sac).

  • Incomplete division after day $13$ results in conjoined twins.

• Dizygotic (Fraternal) Twins:

  • Originate from the simultaneous release and independent fertilization of two separate ova by two different spermatozoa within the same ovulatory cycle.

  • Each conceptus implants independently, developing its own separate extraembryonic membranes.

  • Consistently develop with separate placentas (dichorionic, which may occasionally fuse if implanted adjacent) and separate amniotic sacs (diamniotic).

  • Genetically distinct individuals sharing approximately $50\%$ of their polymorphic alleles, identical to ordinary siblings born at different times; they can be the same sex or different sexes.